Osaka, Japan

Takehiko Yamazaki

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovative Advances by Inventor Takehiko Yamazaki

Introduction

Takehiko Yamazaki, an accomplished inventor based in Osaka, Japan, holds a remarkable portfolio of 11 patents. His work primarily focuses on therapeutic methods that harness mesenchymal stem cells and peptide applications in regenerative medicine. Through his innovative research, he has made significant contributions to the field of medicinal chemistry and therapeutic treatments.

Latest Patents

One of Yamazaki's latest patents involves a drug aimed at disease treatment based on mesenchymal-stem-cell mobilization. In this work, the inventor has identified numerous nuclear proteins present in skin tissue extracts through mass spectrometry. By randomly selecting various partial amino acid sequences of these proteins, he chemically synthesized peptides and explored their efficacy in mobilizing mesenchymal stem cells into peripheral blood. The findings revealed that multiple peptides, despite having completely different amino acid sequences, exhibited this desired activity. Furthermore, fragment peptides derived from nuclear proteins demonstrated therapeutic effects on inflammatory diseases and immune system abnormalities, such as inflammatory bowel disease and psoriasis. This breakthrough lays the foundation for a novel regenerative medicine technology that addresses the limitations of traditional cell transplantation therapy.

Another significant patent from Yamazaki focuses on a therapeutic agent for cardiomyopathy, myocardial infarction, and chronic heart failure. The inventors identified specific HMGB1 fragment peptides that exhibit promising effects on cardiac function improvement, inhibition of cardiomyocyte hypertrophy, and promotion of angiogenesis in animal models. This discovery has led to the development of pharmaceutical compositions that facilitate the prevention and treatment of cardiomyopathy and other related heart conditions.

Career Highlights

Yamazaki has built a successful career in his field, collaborating with esteemed institutions such as Osaka University and Stemrim Inc. His research consistently leads to advancements in understanding and treating a variety of health issues through innovative approaches.

Collaborations

In his research endeavors, Takehiko Yamazaki has worked closely with notable colleagues, including Katsuto Tamai and Yasufumi Kaneda. Their combined expertise has propelled Yamazaki's innovative projects forward, fostering advancements in therapeutic techniques and applications.

Conclusion

Takehiko Yamazaki's contributions to the fields of regenerative medicine and therapeutic drug development highlight his status as a remarkable inventor. His research continues to push the boundaries of current medical practices, offering hope for more effective treatments and better patient outcomes in combating serious health conditions. Enthusiasts of medical innovations and therapeutic advancements will undoubtedly continue to watch Yamazaki's progress with keen interest.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…